Status:
COMPLETED
PPI Sequencing Study
Lead Sponsor:
AstraZeneca
Conditions:
Gastro-Oesophageal Reflux Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess how patients with gastro-oesophageal reflux disease (heartburn) who are currently receiving treatment with a proton pump inhibitor but are still experiencing sym...
Eligibility Criteria
Inclusion
- Persisting symptoms of GORD despite previous treatment with a full dose proton pump inhibitor
- Informed consent
- Over 18 years of age
Exclusion
- Current course of Proton Pump inhibitor treatment for more than 8 weeks prior to enrolment in the study;
- More than 1 other course of PPI treatment in the previous 12 month;
- Previous use of esomeprazole;
- Presence of alarm symptoms.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
End Date :
May 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00384592
Start Date
September 1 2006
End Date
May 1 2007
Last Update
March 11 2009
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Allerton, United Kingdom
2
Research Site
Ashford, United Kingdom
3
Research Site
Atherstone, United Kingdom
4
Research Site
Ayrshire, United Kingdom